NCT03628144 2020-09-10
Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Withdrawn
Clinical Trials
6 trialsNCT03128281 2019-05-30
Pneumoperitoneum Management With Low vs. Higher Pressure
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT01782976 2018-01-19
Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT02420587 2015-04-20
AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT01518140 2013-08-13
BiPAP-Vapotherm RCT
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT00969085 2012-09-07
Trial of Curcumin in Cutaneous T-cell Lymphoma Patients
M.D. Anderson Cancer Center
Phase 2 Withdrawn